Table: Fuso Pharmaceutical - 9-MTH parent results

Fuso Pharmaceutical Industries

12/02/2026 06:36

Feb 12 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             48.27               46.66            61.50    
                 (+3.4 pct)          (+8.9 pct)       (+1.5 pct)  
  Operating          2.37                3.63             3.40    
                 (-34.8 pct)         (+97.2 pct)      (-17.7 pct) 
  Recurring          2.22                3.34             3.30    
                 (-33.7 pct)         (+82.7 pct)      (-12.7 pct) 
  Net                1.68                2.40             2.30    
                 (-29.9 pct)         (+95.8 pct)                  
  EPS            197.24 yen          281.26 yen       269.24 yen  
  Ann Div                             82.00 yen        90.00 yen  
  -Q2 div         45.00 yen           40.00 yen                   
  -Q4 div                             42.00 yen        45.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T